Asia Pacific Genotyping Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product and Services (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology [Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others], Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Others)
The genotyping market in Asia Pacific is expected to grow from US$ 5,365.20 million in 2022 to US$ 17,668.09 million by 2028. It is estimated to grow at a CAGR of 22.0% from 2022 to 2028.
Genotyping compares a DNA sequence to another sample or a reference sequence to discover variations in genetic complement. It detects single-nucleotide polymorphisms (SNPs), which are minor differences in genetic sequence within the population. The human genome has about 660 million SNPs, making them the most prevalent kind of genetic variation. They can explain features such as eye color and hereditary disorders, such as cystic fibrosis and sickle cell anemia, and serve as indicators for developing complicated diseases, such as cancer, diabetes, and Alzheimer's.
The introduction of high-throughput genotyping technologies has greatly advanced our understanding of the genetic components of complex disorders, such as T2D. Additionally, by comparing polymorphisms in two distinct populations (one healthy and one diseased), genome-wide association studies (GWAS) can uncover links between SNPs and common illness risk. GWAS can begin to untangle the molecular mechanisms underlying disease states by finding probable causative variables risk stratification. Single-celled organisms, such as bacteria, even have SNPs. SNP genotyping can discriminate between microorganism isolates and might even be accustomed to characterizing antibiotic resistance strains. SNP-based strain detection has relevance in each clinical and pharmaceutical analysis and has been used to study the spread of infectious diseases in humans. As per the WHO, in 2020, more than 1.7 million children in India were born with congenital disabilities, for which genetic or chromosomal abnormalities are the major causal agent.
Since these conditions are difficult to identify clinically, genotyping is the backbone of diagnostic testing in the population. This rising adoption of prenatal genetic screening to examine children's chromosomal anomalies could prove to be a significant driving factor. Over the last decade, next-generation sequencing (NGS) technology has enabled simultaneous testing of multiple disease genes, from targeted gene panels to exome sequencing (ES) and genomic sequencing (GS). GS is quickly becoming a practical first-stage test as costs decrease and performance improves.
More and more studies show that GS can detect an unprecedented range of pathogenic abnormalities in a single laboratory. GS has the potential to provide patients with unbiased, rapid, and accurate molecular diagnostics that transcend diverse clinical indications and complex conditions. Therefore, the use in drug development for genetic and rare diseases will be one of the key factors driving the growth of the genotyping markets over the next few years.
Asia Pacific Genotyping Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Genotyping Market Segmentation
The Asia Pacific genotyping market is segmented by products and services, technology, application, end user, and country. Based on products and services, the market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagents and kits segment is dominating the market in 2022.
Based on technology, the market is segmented into microarrays, capillary electrophoresis, sequencing, matrix-assisted laser desorption/ionization-time of flight (Maldi-ToF) mass spectrometry, polymerase chain reaction (PCR), and others. The PCR segment is dominating the market in 2022.
Based on application, the market is segmented into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. The diagnostics and personalized medicine segment is dominating the market in 2022.
Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others. The diagnostics and research laboratories segment is dominating the market in 2022.
Based on country, the market is segmented into Japan, China, India, Australia, South Korea, and the rest of Asia Pacific. Further, Japan dominated the market in 2022.
A few key players dominating the Asia Pacific genotyping market are BioTek Instruments, Inc.; Eurofins Genomics; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Integrated DNA Technologies, Inc.; MERCK KGaA; QIAGEN; Thermo Fisher Scientific Inc; TrimGen Corporation; and XCELRIS GENOMICS.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Genotyping Market – By Product and Services
1.3.2 APAC Genotyping Market – By Technology
1.3.3 APAC Genotyping Market – By Application
1.3.4 APAC Genotyping Market – By End User
1.3.5 APAC Genotyping Market – By Country
2. APAC Genotyping Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Genotyping Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Genotyping Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Use of Genotyping in Drug Development for Genetic and Rare Diseases
5.1.2 Technological Advancements and Rising R&D Investments in Pharmaceutical and Biotechnology
5.2 Market Restraints
5.2.1 High Cost of Equipment and Shortage of skilled Professionals required for Genotyping process
5.3 Market Opportunities
5.3.1 Wide Applications of Genotyping
5.4 Future Trends
5.4.1 Rising focus on Personalized Medicine
5.5 Impact analysis
6. Genotyping Market– APAC Analysis
6.1 APAC Genotyping Market Revenue Forecast and Analysis
7. APAC Genotyping Market– by Product and Services
7.1 Overview
7.2 APAC Genotyping Market, By Product and Services, 2022 & 2028 (%)
7.3 Reagents and Kits
7.3.1 Overview
7.3.2 Reagents and Kits: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Genotyping Services
7.4.1 Overview
7.4.2 Genotyping Services: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Bioinformatics
7.5.1 Overview
7.5.2 Bioinformatics: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Instruments
7.6.1 Overview
7.6.2 Instruments: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
8. APAC Genotyping Market– by Technology
8.1 Overview
8.2 APAC Genotyping Market Share by Technology - 2022 & 2028 (%)
8.3 Polymerase Chain Reaction (PCR)
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.4 Capillary Electrophoresis (CE)
8.4.1 Overview
8.4.2 Capillary Electrophoresis: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.5 Sequencing
8.5.1 Overview
8.5.2 Sequencing: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.6 Microarrays
8.6.1 Overview
8.6.2 Microarrays: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.7 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry
8.7.1 Overview
8.7.2 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Genotyping Market–by Application
9.1 Overview
9.2 APAC Genotyping Market Share by Application - 2022 & 2028 (%)
9.3 Diagnostics and Personalized Medicine
9.3.1 Overview
9.3.2 Diagnostics and Personalized Medicine: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.4 Pharmacogenomics
9.4.1 Overview
9.4.2 Pharmacogenomics: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.5 Animal Genetics
9.5.1 Overview
9.5.2 Animal Genetics: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.6 Agricultural Biotechnology
9.6.1 Overview
9.6.2 Agricultural Biotechnology: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10. APAC Genotyping Market– by End User
10.1 Overview
10.2 APAC Genotyping Market Share by End User- 2022 & 2028 (%)
10.3 Diagnostic and Research Laboratories
10.3.1 Overview
10.3.2 Diagnostic and Research Laboratories: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.4 Pharmaceutical and Biopharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biopharmaceutical Companies: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.5 Academic Institutes
10.5.1 Overview
10.5.2 Academic Institutes: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: APAC Genotyping Market Revenue and Forecast to 2028 (US$ Million)
11. APAC Genotyping Market– Country Analysis
11.1 APAC Genotyping Market Revenue and Forecasts to 2028
11.1.1 Overview
11.1.3 APAC: Genotyping Market Revenue and Forecasts to 2028, By Country (%)
11.1.3.1 Japan: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.1.1 Overview
11.1.3.1.2 Japan: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.1.3 Japan: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.1.4 Japan: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.1.3.1.5 Japan: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.1.6 Japan: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.3.2 China: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.2.1 Overview
11.1.3.2.2 China: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.2.3 China: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.2.4 China: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.1.3.2.5 China: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.2.6 China: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.3.3 India Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.3.1 Overview
11.1.3.3.2 India: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.3.3 India: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.3.4 India: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.1.3.3.5 India: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.3.6 India: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.3.4 South Korea: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.4.1 Overview
11.1.3.4.2 South Korea: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.4.3 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.4.4 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.1.3.4.5 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.4.6 South Korea: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.3.5 Australia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.5.1 Overview
11.1.3.5.2 Australia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.5.3 Australia: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.5.4 Australia: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.1.3.5.5 Australia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.5.6 Australia: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.3.6 Rest of APAC: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3.6.1 Overview
11.1.3.6.2 Rest of APAC: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3.6.3 Rest of APAC: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.6.4 Rest of APAC: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.1.3.6.5 Rest of APAC: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.6.6 Rest of APAC: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
12. APAC Genotyping Market Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 INTEGRATED DNA TECHNOLOGIES, INC. (DANAHER)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MERCK KGaA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 EUROFINS GENOMICS
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 THERMO FISHER SCIENTIFIC INC.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BioTek Instruments, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 XCELRIS GENOMICS
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 TRIMGEN CORPORATION
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 SWOT Analysis
13.9.5 Key Developments
13.10 Illumina, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. The pharmaceutical company partnered with genomic health databases
Table 2. APAC Genotyping Market –Revenue and Forecast to 2028 (US$ Million)
Table 3. Japan: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 4. Japan: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 5. Japan: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 6. Japan: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 7. China: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 8. China: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 9. China: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 10. China: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 11. India: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 12. India: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 13. India: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 14. India: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 15. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 16. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 17. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 18. South Korea: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 19. Australia: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 20. Australia: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 21. Australia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 22. Australia: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 23. Rest of APAC: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 24. Rest of APAC: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 25. Rest of APAC: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 26. Rest of APAC: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 27. Organic Developments Done By Companies
Table 28. Inorganic Developments Done By Companies
Table 29. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC Genotyping Market Segmentation
Figure 2. APAC Genotyping Market – By Country
Figure 3. APAC Genotyping Market Overview
Figure 4. Reagents and Kits Held Largest Share by Product and Services of APAC Genotyping Market
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. APAC: PEST Analysis
Figure 7. Experts Opinion
Figure 8. APAC Genotyping Market Impact Analysis of Driver and Restraints
Figure 9. APAC Genotyping Market– Revenue Forecast and Analysis – 2022 - 2028
Figure 10. APAC Genotyping Market, by Product and Services, 2022 & 2028 (%)
Figure 11. Reagents and Kits: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Genotyping Services: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Bioinformatics: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Instruments: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. APAC Genotyping Market Share by Technology - 2022 & 2028 (%)
Figure 16. Polymerase Chain Reaction: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Capillary Electrophoresis: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Sequencing: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Microarrays: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Others: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. APAC Genotyping Market Share by Application - 2022 & 2028 (%)
Figure 23. Diagnostics and Personalized Medicine: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Pharmacogenomics: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Animal Genetics: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Agricultural Biotechnology: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Others: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. APAC Genotyping Market Share by End User- 2022 & 2028 (%)
Figure 29. Diagnostic and Research Laboratories: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Pharmaceutical and Biopharmaceutical Companies: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Academic Institutes: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Others: APAC Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. APAC Genotyping Market Overview, by Country (2022)
Figure 34. APAC: Genotyping Market Revenue and Forecasts to 2028, By Country (%)
Figure 35. Japan: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. China: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. India: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. South Korea: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Australia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. Rest of APAC: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
- BioTek Instruments, Inc.
- Eurofins Genomics
- F. Hoffmann-La Roche Ltd.
- Illumina, Inc.
- Integrated DNA Technologies, Inc.
- MERCK KGaA
- QIAGEN
- Thermo Fisher Scientific Inc
- TrimGen Corporation
- XCELRIS GENOMICS
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific Genotyping Market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Genotyping Market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Genotyping Market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution